EMD387008, a New Antidiabetic Compound, Inhibits Hepatic Gluconeogenesis through Gluconeogenic Gene Regulation and AMPK Activation.Published in:Diabetes, 2007, v. 56, p. A157By:Raynal, Sophie;Audet, Annick;MéSangeau, Didier;Durbin, Philippe;Augert, GuyPublication type:Article